Compass Therapeutics, Inc. (CMPX) Guidance & Earnings Results

On 2025-08-11 Compass Therapeutics, Inc. issued guidance: "Tovecimig secondary endpoint analysis (OS/PFS) expected Q1 2026; CTX-8371 expansion cohorts Q4 2025; CTX-10726 IND Q4…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CMPXCompass Therapeutics, Inc.Follow CMPX — free

Biotechnology · Healthcare

—

Price chart with a free account

Market cap: 137.0M
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 11 Nov, in 18 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
11 Aug 25	—	Tovecimig secondary endpoint analysis (OS/PFS) expected Q1 2026; CTX-8371 expansion cohorts Q4 2025; CTX-10726 IND Q4 2025

Compass Therapeutics, Inc. — questions

What guidance did Compass Therapeutics, Inc. give?: On 2025-08-11: "Tovecimig secondary endpoint analysis (OS/PFS) expected Q1 2026; CTX-8371 expansion cohorts Q4 2025; CTX-10726 IND Q4 2025"
When does Compass Therapeutics, Inc. report earnings?: Compass Therapeutics, Inc.'s next earnings report is expected on 2026-11-11.

Every figure on this page comes from Compass Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.